Treatment Approach for Gastric Cancer
ASCO® 2023 Insights: "STAR-221 Phase 3 Trial - Domvanalimab, Zimberelimab, & Chemo vs. Nivo & Chemo in Previously Untreated, Locally Advanced, Unresectable or Metastatic GC/GEJC/EC"
Login to view comments.
Click here to Login
Treatment Approach for Gastric Cancer